RY 169.88 -1.0542% SHOP 144.59 -0.959% TD 77.85 -0.1667% ENB 59.62 -0.5505% BN 78.53 -0.971% TRI 223.92 -0.2495% CNQ 47.03 -0.0213% CP 102.49 -0.5627% CNR 147.77 -0.8787% BMO 131.32 -0.0685% BNS 78.4 0.0255% CSU 4463.7002 0.6222% CM 90.42 0.6344% MFC 44.91 -1.3184% ATD 77.0 -0.7604% NGT 60.01 -0.4149% TRP 68.0 -2.2989% SU 56.965 -0.4282% WCN 260.14 -0.653% L 176.45 0.7135%
Last update at 2024-01-23T20:03:10.600004Z
3 TSX Stocks Estimated To Be Trading At Discounts Of Up To 47.3%
Mon 21 Oct 24, 12:04 PM3 TSX Stocks That May Be Priced Below Their Estimated Value In October 2024
Tue 15 Oct 24, 12:03 PM3 TSX Stocks Estimated To Be Trading At Discounts Of Up To 50%
Mon 14 Oct 24, 12:06 PMTSX Stocks That May Be Trading Below Estimated Value In October 2024
Fri 04 Oct 24, 12:09 PM3 TSX Stocks Trading Up To 27.3% Below Intrinsic Value Estimates
Wed 02 Oct 24, 12:10 PMThree TSX Stocks Estimated To Be Trading Below Intrinsic Value
Thu 19 Sep 24, 12:02 PMTSX Stocks That May Be Trading Below Fair Value Estimates For September 2024
Wed 18 Sep 24, 12:03 PMTop TSX Stocks Estimated To Be Undervalued In September 2024
Tue 17 Sep 24, 12:07 PM3 TSX Stocks That Could Be Trading Below Their Estimated Value
Mon 16 Sep 24, 12:05 PM3 TSX Stocks Estimated To Be Trading At Up To 48% Discount
Mon 09 Sep 24, 12:05 PM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 8.99M | 12.50M | 26.36M | 8.80M | 10.34M |
| Minority interest | - | - | - | - | - |
| Net income | 6.22M | 9.13M | 31.53M | 8.53M | 10.18M |
| Selling general administrative | 73.36M | 60.04M | 57.71M | 45.27M | 30.68M |
| Selling and marketing expenses | - | - | - | - | 0.27M |
| Gross profit | 84.68M | 73.41M | 80.11M | 56.01M | 48.58M |
| Reconciled depreciation | 15.63M | 11.31M | 9.58M | 6.40M | 3.78M |
| Ebit | 8.25M | 11.58M | 26.78M | 8.75M | 10.52M |
| Ebitda | 24.57M | 23.79M | 34.13M | 15.62M | 14.30M |
| Depreciation and amortization | 16.32M | 12.21M | 7.34M | 6.87M | 3.78M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 8.25M | 11.58M | 26.78M | 8.75M | 17.05M |
| Other operating expenses | 130.23M | 105.03M | 106.86M | 71.04M | 48.23M |
| Interest expense | 0.20M | 0.32M | 0.51M | 0.31M | 0.18M |
| Tax provision | 2.77M | 3.38M | -5.16700M | 0.27M | 0.16M |
| Interest income | 0.74M | 0.92M | 0.42M | 0.31M | 0.18M |
| Net interest income | -0.19700M | -0.31800M | -0.50900M | -0.31400M | -0.18100M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 2.77M | 3.38M | -5.16700M | 0.27M | 0.16M |
| Total revenue | 138.83M | 117.06M | 131.31M | 80.26M | 65.27M |
| Total operating expenses | 76.08M | 61.38M | 55.66M | 46.79M | 31.54M |
| Cost of revenue | 54.15M | 43.65M | 51.20M | 24.25M | 16.69M |
| Total other income expense net | 0.74M | 0.92M | -0.41800M | 0.05M | -6.70600M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 6.22M | 9.13M | 31.53M | 8.53M | 10.18M |
| Net income applicable to common shares | 6.22M | 9.13M | 31.53M | 8.53M | 9.51M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 117.04M | 117.96M | 112.56M | 82.60M | 53.52M |
| Intangible assets | - | - | - | - | - |
| Earning assets | - | - | - | - | - |
| Other current assets | 3.85M | 1.73M | 1.51M | 1.56M | 0.82M |
| Total liab | 19.95M | 23.14M | 30.87M | 38.90M | 18.49M |
| Total stockholder equity | 97.09M | 94.82M | 81.69M | 43.70M | 35.03M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 11.09M | 8.88M | 12.94M | 9.05M | 7.91M |
| Common stock | 15.12M | 14.01M | 9.18M | 3.37M | 0.07M |
| Capital stock | 15.12M | 14.01M | 9.18M | 3.37M | 0.07M |
| Retained earnings | 69.85M | 73.33M | 65.64M | 34.11M | 29.57M |
| Other liab | 0.89M | 0.56M | 0.86M | 2.32M | 1.12M |
| Good will | - | - | - | - | - |
| Other assets | 4.71M | 5.65M | 9.60M | 0.01M | 0.00000M |
| Cash | 16.91M | 28.41M | 30.98M | 13.36M | 10.41M |
| Cash and equivalents | 11.00M | 16.46M | 30.98M | 13.36M | 10.41M |
| Total current liabilities | 18.86M | 17.81M | 23.02M | 25.91M | 16.98M |
| Current deferred revenue | 4.62M | 3.75M | 3.41M | 3.31M | - |
| Net debt | -16.22000M | -21.89000M | -19.84600M | 6.16M | -6.98800M |
| Short term debt | 0.49M | 1.94M | 4.58M | 8.84M | 3.03M |
| Short long term debt | - | 1.48M | 1.84M | 1.75M | - |
| Short long term debt total | 0.69M | 6.52M | 11.13M | 19.51M | 3.42M |
| Other stockholder equity | 12.12M | 7.75M | 7.32M | 6.38M | 5.39M |
| Property plant equipment | 68.44M | 62.85M | 55.06M | 54.77M | 30.56M |
| Total current assets | 39.74M | 47.31M | 47.17M | 27.81M | 22.96M |
| Long term investments | 4.16M | 2.16M | 0.73M | - | - |
| Net tangible assets | 97.09M | 94.82M | 81.69M | 43.70M | 32.57M |
| Short term investments | - | - | - | - | - |
| Net receivables | 15.40M | 14.72M | 12.37M | 11.53M | 12.07M |
| Long term debt | 0.00000M | 4.31M | 5.80M | 7.63M | 0.00000M |
| Inventory | 3.57M | 2.46M | 2.31M | 1.36M | 2.89M |
| Accounts payable | 2.65M | 3.24M | 2.10M | 4.70M | 5.88M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | - | -0.27800M | -0.45100M | -0.15700M | -8.82200M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | 9.18M | 3.37M | 0.07M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 1.59M | 0.86M | 0.86M | 0.01M | 30.56M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 77.30M | 70.65M | 65.39M | 54.78M | 30.56M |
| Capital lease obligations | 0.69M | 0.73M | 3.50M | 10.13M | 3.42M |
| Long term debt total | 0.20M | 4.57M | 6.56M | 10.67M | 0.39M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -23.97600M | -0.59900M | -8.41500M | -12.81100M | -5.30100M |
| Change to liabilities | 0.55M | 0.48M | 0.31M | 1.51M | 3.31M |
| Total cashflows from investing activities | -23.97600M | -19.74600M | -8.41500M | -12.81100M | -5.30100M |
| Net borrowings | -5.83800M | -3.99900M | -10.94500M | -2.20800M | -10.16200M |
| Total cash from financing activities | -15.26600M | -5.32100M | -9.06900M | -3.33400M | -11.75200M |
| Change to operating activities | -0.28900M | -4.24800M | 1.50M | 1.73M | 3.11M |
| Net income | 6.22M | 9.13M | 31.53M | 8.53M | 10.18M |
| Change in cash | -11.49400M | -2.57300M | 17.63M | 2.94M | 5.32M |
| Begin period cash flow | 28.41M | 30.98M | 13.36M | 10.41M | 5.10M |
| End period cash flow | 16.91M | 28.41M | 30.98M | 13.36M | 10.41M |
| Total cash from operating activities | 27.75M | 22.49M | 35.11M | 19.09M | 22.37M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 15.63M | 11.31M | 9.58M | 6.40M | 3.78M |
| Other cashflows from investing activities | -1.07800M | -0.00300M | 4.63M | 0.57M | 0.81M |
| Dividends paid | - | - | - | - | - |
| Change to inventory | 0.30M | -0.21200M | -2.30300M | -0.30600M | -1.25400M |
| Change to account receivables | -12.56700M | -7.34500M | -9.95500M | -12.50600M | -5.25300M |
| Sale purchase of stock | -9.71100M | -1.43400M | 1.88M | -1.52200M | -1.59400M |
| Other cashflows from financing activities | 0.28M | 0.11M | 1.88M | 10.23M | 0.00400M |
| Change to netincome | 16.03M | 15.62M | 4.20M | 13.80M | 9.16M |
| Capital expenditures | 22.90M | 19.74M | 13.04M | 13.38M | 6.11M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -10.13500M | -13.56100M | -10.20100M | -9.53200M | -0.74800M |
| Stock based compensation | 5.20M | 5.15M | 4.88M | 3.89M | 2.70M |
| Other non cash items | 9.08M | 6.58M | 16.10M | 9.81M | 6.45M |
| Free cash flow | 4.85M | 2.75M | 22.07M | 5.70M | 16.25M |
Sector: Healthcare Industry: Medical Devices
| Company | Change (CAD) | Price (CAD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| VMD Viemed Healthcare Inc |
- -% | - | 32.66 | 16.72 | 2.30 | 2.69 | 2.31 | 11.74 |
| HTL Hamilton Thorne Ltd. |
-0.01 0.44% | 2.24 | - | 45.87 | 4.73 | 3.92 | 3.64 | 42.65 |
| PRN Profound Medical Corp |
-0.36 3.31% | 10.50 | - | - | 37.22 | 5.39 | 23.36 | -7.9326 |
| QIPT Quipt Home Medical Corp. |
-0.02 0.59% | 3.38 | - | 54.05 | 0.66 | 1.06 | 0.78 | 3.84 |
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
625 East Kaliste Saloom Road, Lafayette, LA, United States, 70508
| Name | Title | Year Born |
|---|---|---|
| Mr. Casey Hoyt | CEO & Director | 1977 |
| Mr. Michael B. Moore CRT | Pres | 1978 |
| Mr. Trae Paul Fitzgerald | Chief Financial Officer | 1989 |
| Mr. William Todd Zehnder | COO & Director | 1975 |
| Dr. William Dana Frazier M.D. | Chief Medical Officer & Director | 1958 |
| Mr. Jeremy Trahan | Chief Legal Officer and Exec. VP of Acquisitions & Strategic Transactions | NA |
| Mr. Patrick Eagan | Gen. Counsel | 1979 |
| Mr. Michael Freeman | Chief Bus. Devel. Officer | NA |
| Mr. Robert Grossman LLB | Corp. Sec. | 1974 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
CA 
AU
UK
US
NZ
Please wait processing your request...